hotspot -WSS

hotspot

author：explore 2025-10-02 06:18:56 - browse：19

Rachel Haurwitz of Caribou Biosciences — Rachel Haurwitz, CEO of Caribou Biosciences. Elizabeth D. Herman for STAT

Caribou Biosciences said Thursday that its off-the-shelf CAR-T therapy induced durable, complete remissions in patients with advanced B-cell lymphoma that move it closer to the benchmarks set by more established, patient-specific CAR-T therapies.

In an update to an early-stage study, 44% of the 16 patients treated with Caribou’s on-demand therapy, called CB-010, achieved a complete remission lasting a minimum of six months — a key threshold of durability.

The CB-010 result is still preliminary, but it begins to compare favorably to currently approved CAR-T therapies, which must be custom made for each patient and have shown durable remission rates in the range of 36-40%, said Caribou CEO Rachel Haurwitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Merck, Daiichi strike cancer drug pact worth up to $22 billion

knowledge

Wikipedia

WSS

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

A public health expert passes on football's full body collisions for youths

Mom launches Girl Scout troop for LGBTQ youth in Texas

FDA approves first new drug developed for postpartum depression

Patients, doctors are clashing about side effects of hormonal birth control

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

hotspot

hotspot

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Affirmative action in medical school literally saved lives

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Altering the blood type of lungs raises potential for universal organs for transplants

Duchenne breakthrough therapy leaves behind pioneering families

Biogen nominates mother of director’s child to replace him on board

Medicare details structure of new drug price negotiation program

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Wikipedia

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Bispecific antibodies are next new thing in cancer immunotherapy

Health tech investors get more selective as pandemic boom fades

Can medical device makers keep up in the race to treat obesity?

entertainment

knowledge

Wikipedia

hotspot